Francesca Palandri

73PUBLICATIONS
217CO-AUTHORS
PharmacogenomicsMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (73)

|Oct 13, 2026
VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Jul 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.

|Jun 30, 2026
TRANSFORM-1 phase 3 study: efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

Pageof 13

Frequent Collaborators

29 joint publications

Massimo Breccia

27 joint publications

Alessandra Iurlo

21 joint publications

Mario Tiribelli

21 joint publications

Valerio De Stefano